Relay Therapeutics, Inc. Common Stock (NASDAQ: RLAY) last traded at $17.89, up 0.06% on the session. The quote above updates while this page is open; the figures below are drawn from Relay Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Relay Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker RLAY. Its market capitalisation is $3.92 billion.
Valuation measures for Relay Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.92B |
|---|---|
| Enterprise value | $3.88B |
| Price / sales | 378.82 |
| Price / book | 4.40 |
| Beta | 1.51 |
Trailing-twelve-month figures tagged in Relay Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $10.35M |
|---|---|
| Net income (TTM) | -$286.04M |
| EPS (TTM) | -$1.56 |
| Operating margin | -2999.67% |
| Return on equity | -32.14% |
| Cash | $121.19M |
Range and volume for RLAY over the past 52 weeks.
| 52-week high | $21.27 |
|---|---|
| 52-week low | $5.85 |
| Volume | 701.3K |
| Average volume | 2.74M |
| Previous close | $17.88 |
Invest a chosen dollar amount in Relay Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell RLAY.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.